$4.47
-0.21-4.48%
At Close: -
$4.50
0.030.67%
After Hours: 8:42 AM EDT
15 minutes delayed
NeuroBo Pharmaceuticals
NRBONASDAQ
NeuroBo Pharmaceuticals (NRBO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
NeuroBo Pharmaceuticals (NASDAQ:NRBO) Stock Quotes, Forecast and News Summary
NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO) stock price, news, charts, stock research, profile.
| Open | $4.60 |
| Close | $4.47 |
| Volume / Avg. | 33.67K / 57.71K |
| Day Range | 4.47 - 4.80 |
| 52 Wk Range | 2.90 - 6.75 |
| Market Cap | $44.98M |
| P/E Ratio | 15.60 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 0.82% |
| Days to Cover | 5.95 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About NeuroBo Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on devel...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NeuroBo Pharmaceuticals (NRBO) stock?
You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ:NRBO) through any online brokerage.
Who are NeuroBo Pharmaceuticals (NRBO) competitors?
Other companies in NeuroBo Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), BioLine Rx (NASDAQ:BLRX) and Cue Biopharma (NASDAQ:CUE).
What is the target price for NeuroBo Pharmaceuticals (NRBO) stock?
There is no analysis for NeuroBo Pharmaceuticals.
What is the forecast for NeuroBo Pharmaceuticals (NRBO) stock?
NeuroBo Pharmaceuticals has a consensus price target of $8.00.
Current stock price for NeuroBo Pharmaceuticals (NRBO)?
The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $4.5 last updated July 3, 2024 at 8:42 AM EDT.
Does NeuroBo Pharmaceuticals (NRBO) pay a dividend?
There are no upcoming dividends for NeuroBo Pharmaceuticals.
When is NeuroBo Pharmaceuticals (NASDAQ:NRBO) reporting earnings?
NeuroBo Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is NeuroBo Pharmaceuticals (NRBO) going to split?
There is no upcoming split for NeuroBo Pharmaceuticals.
What sector and industry does NeuroBo Pharmaceuticals (NRBO) operate in?
NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.